Clinical Study of SPH3348 Tablets, a C-Met Inhibitor, in Patients with Advanced Solid Tumors

NCT05088070 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor

Interventions

DRUG: SPH 3348
DRUG: SPH 3348
DRUG: SPH 3348
DRUG: SPH 3348
DRUG: SPH 3348
DRUG: SPH 3348

Sponsor

Shanghai Pharmaceuticals Holding Co., Ltd